By Sydney Kodatsky | Monday, September 5, 2016 - 7:30am
Over $1.5 million committed to research grants through 2018.
Answering TTP Foundation understands the need for biomedical, clinical and population health research and accepts research proposals internationally. We are excited to announce the funding of three new promising international resesarch grants beginning September 2016.
Deeper insight into the misrouted immune response to ADAMTS13 in acquired TTP - a prerequisite for better patient management. Prof. Dr. J. A. Kremer Hovinga, Department of Hematology and Central Hematology Laboratory, Inselpsital, Bern University Hospital (September 30, 2016 to September 29, 2018).
Development of improved assays for the diagnosis of TTP. D. W. Chung, PhD, Bloodworks Research Institute, Seattle, WA (September 30, 2016 to September 29, 2018)
A prospective randomised controlled trial of low-dose versus standard dose rituximab for prevention of relapses in acquired TTP., Dr. M. Thomas, Consultant Haematologist, University College London Hospital, London (September 30, 2016 to September 29, 2018)